Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1b, Proof of Concept, Dose-Ranging Study to Evaluate the Safety of the Coadministration of Ascending Doses of ANS-6637 and Ethanol in Healthy Male Moderate Drinkers

Trial Profile

A Phase 1b, Proof of Concept, Dose-Ranging Study to Evaluate the Safety of the Coadministration of Ascending Doses of ANS-6637 and Ethanol in Healthy Male Moderate Drinkers

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2018

At a glance

  • Drugs ANS 6637 (Primary)
  • Indications Alcoholism
  • Focus Adverse reactions; Proof of concept
  • Sponsors Amygdala Neurosciences
  • Most Recent Events

    • 12 Sep 2018 Results presented in an Amygdala Neurosciences media release.
    • 12 Jan 2018 Status changed from recruiting to completed.
    • 18 Oct 2017 According to an Altasciences media release, Altasciences are working with Amygdala Neurosciences to conduct this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top